[1]
. R. Parihar and . B. K. Sharma, “QSAR rationales for the dipeptidyl peptidase-4 (DPP-4) inhibitors: The imidazolopyrimidine amides”, GSC Biol. Pharm. Sci., vol. 11, no. 3, pp. 130–144, Jun. 2020.